The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography

This study aimed to determine the values of the half‐effective dose (ED(50)) and 95% effective dose (ED(95)) of remimazolam besylate used in the procedural sedation of endoscopic retrograde cholangiopancreatography (ERCP). Sixty patients who fulfilled the inclusion and exclusion criteria of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Dan‐Dan, Gu, Jin, Li, Juan, Yu, Wan‐Qiu, Liu, De‐Xing, Zhao, Li‐Jin, Zhu, Guo‐Hua, Yang, Xin‐Xin, Tian, Jin, Tian, Qi, Zhu, Zhao‐Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527792/
https://www.ncbi.nlm.nih.gov/pubmed/37786755
http://dx.doi.org/10.1002/ibra.12072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527792/
https://www.ncbi.nlm.nih.gov/pubmed/37786755
http://dx.doi.org/10.1002/ibra.12072

Ejemplares similares